Melina Wiedmann
Biographic Data
| ID | 7965976 |
|---|---|
| NAME | Melina Wiedmann |
| GIVEN NAMES | Melina |
| FAMILY NAME | Wiedmann |
| SIGNATURE | WIEDMANN M |
| AFFILIATIONS | Technische Universität Dresden |
| ORCID | 0000-0001-7250-4329 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Evaluation of the multimodal Delta therapy for adolescents with substance use disorders
DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)
Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…
No prominent works on this page.
Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…
Evaluation of the multimodal Delta therapy for adolescents with substance use disorders
DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)
Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Abstinence (1 works) · Attention Deficit Hyperactivity Disorder (1 works) · Behavioral and Psychological Studies (1 works) · Cannabis (1 works) · Cannabis and Cannabinoid Research (1 works) · Child and Adolescent Psychosocial and Emotional Development (1 works) · Clinical Psychology (1 works)